R. Halpin

CD19-positive antibody-secreting cells provide immune memory.

Y. Shrestha, J. Carrell, R. Herbst, 2018, Blood advances.

Ferroptosis of tumour neutrophils causes immune suppression in cancer

J. Tobias, G. Kar, A. Greenberg, 2022, Nature.

Impaired Tumor‐Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD‐1 Blockade

T. Creasy, L. Fournel, N. Roche, 2018, American journal of respiratory and critical care medicine.

Resistance to durvalumab and durvalumab plus tremelimumab is associated with functional STK11 mutations in non-small-cell lung cancer patients and is reversed by STAT3 knockdown.

Ricardo J. Miragaia, Y. Shrestha, Song Wu, 2021, Cancer discovery.

Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional STK11 Mutations in Patients with Non–Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown

Ricardo J. Miragaia, Y. Shrestha, J. Barrett, 2021 .

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

T. Creasy, S. Warren, K. Leroy, 2019, Journal of Translational Medicine.

Evaluation of ultra-low input RNA sequencing for the study of human T cell transcriptome

Y. Shrestha, S. Rieder, R. Raja, 2019, Scientific Reports.

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

T. Creasy, K. Leroy, F. Goldwasser, 2019, Journal of Translational Medicine.